NEW YORK (TheStreet) -- BG Medicine (BGMD) plunged Wednesday after the diagnostics company reported first-quarter results that came up short of analysts' expectations.
The company reported a loss of 8 cents a share, which aligned with the estimate of a loss of 8 cents a share. Revenue totaled $739,000, which came up short of the estimate of $1.3 million.
The stock was down 15.75% to $1.07 at 1:46 p.m.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Must Read: Warren Buffett's 10 Favorite Growth Stocks
BGMD data by YCharts
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.
After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers